MAM
GILD icon

McLean Asset Management’s Gilead Sciences GILD Stock Holding History

McLean Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$253K Buy
1,812
+15
+0.8% +$2.1K 0.04% 146
2025
Q4 		$223K Buy
1,797
+13
+0.7% +$1.58K 0.04% 162
2025
Q3 		$203K Buy
+1,784
New +$203K 0.04% 167

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

McLean Asset Management's GILD Position: Q1 2026 in Review

McLean Asset Management increased its Gilead Sciences (GILD) stake by 0.83% in Q1 2026, buying an estimated $2.1K and bringing the position to 1,812 shares worth $253K. The position accounts for 0.04% of the portfolio, ranked #146.

McLean Asset Management first reported a position in GILD in Q3 2025 and has held it in 3 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • McLean Asset Management held 1,812 shares of Gilead Sciences worth $253K as of Q1 2026.
  • McLean Asset Management bought 15 Gilead Sciences shares in Q1 2026, an estimated $2.1K.
  • Gilead Sciences made up 0.04% of McLean Asset Management's portfolio in Q1 2026, its #146 holding.
  • McLean Asset Management first reported a position in Gilead Sciences in Q3 2025 and has held it in 3 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on McLean Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.